In January 2009 the FDA began requiring Bayer Healthcare Pharmaceuticals, the maker of the birth control pill Yaz to launch a new advertising campaign to correct claims regarding headaches and acne. Continue reading ⇒
Yaz and Yasmin
Yaz and Yasmin are fourth generation birth control pills manufactured by Bayer Healthcare. First approved by the FDA in 2001 (Yasmin) and 2006 (Yaz), there is now increasing concern about the safety of the drugs. The FDA has received reports of more than 50 deaths among Yaz and Yasmin users. Some Yaz and Yasmin victims were in their teens. Many teens took the pills to treat acne after seeing television commercials promoting this off label use. The FDA subsequently ordered the company to discontinue the advertising campaign.
Yaz and Yasmin Facts:
There are continuing concerns for Yaz and Yasmin users from increasing reports of cardiac arrhythmia, cardiac arrest, intracardiac thrombus (blood clots in the heart), pulmonary embolism (blood clot in the lungs) and strokes.
These reports have indicated that the risk of developing blood clots, pulmonary thromboembolism, heart attack, stroke and death, may be significantly higher with Yaz and Yasmin than with other oral contraceptives.
Pulmonary thromboembolism is a sudden blockage in a lung artery, usually due to a blood clot that traveled to the lung from the leg, but clots can also form in the pelvic vein. Symptoms may include shortness of breath, difficulty breathing, anxiety, chest pain, fainting and convulsions.
Usage:
Yaz is different than most other oral contraceptives as it consists of 24 active pills as opposed to 21 and 4 placebo. It is claimed that YAZ keeps you on active pills for three additional days, which helps hormone levels stay even.
Yasmin is administered during a 28 day cycle with 21 active pills and 7 inactive pills.
Litigation:
Lawsuits are being filed on behalf of young women who were using Yaz and Yasmin and suffered strokes, heart attacks, blood clots, pulmonary embolism, other serious injuries or death. These suits allege the manufacturer of the pills was aware of these serious risks and yet continued to aggressively market it to young women. The FDA has already cited the company for its over aggressive marketing.If you or a loved one have been injured by Yaz or Yasmin please fill out our contact form and an experienced DrugSettlement.com attorney or representative will contact you for a free and confidential case evaluation.
